C & O PHARM TECH (HLDGS) LTD: ANNOUNCEMENT OF CESSATION AS EXECUTIVE DIRECTOR

Announcement of Cessation of Executive Director
* Asterisks denote mandatory information
Name of Announcer *	C & O PHARM TECH (HLDGS) LTD
Company Registration No.	33963
Announcement submitted on behalf of	C & O PHARM TECH (HLDGS) LTD
Announcement is submitted with respect to *	C & O PHARM TECH (HLDGS) LTD
Announcement is submitted by *	Gao Bin
Designation *	Executive Director
Date & Time of Broacast	09-Dec-2010 20:13:46
Announcement No.	00126
Price Sensitivity	No

>> Announcement Details

The details of the announcement start here ...

Name *	Wu Su Min
Age *	44
Is Effective Date of Cessation known? *	Yes
Effective Date of Resignation	09/12/2010
Detailed Reason(s) for cessation *	Reconstitution of the Board upon completion of purchase of a strategic stake in C & O Pharmaceutical Technology (Holdings) Limited by Sumitomo Corporation.
Is there any difference of opinion on material matters between the person and the Board of directors? *	No
If yes, please elaborate *	NA
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? *	No
Date of Appointment to current position *	12/08/2005
Job Title *	Executive Director
Role and responsibilities *	Overseeing the production.
Does the AC have a minimum of 3 members (taking into account this cessation) *	Yes
Number of Independent Directors currently resident in Singapore (taking into account this resignation) *	2
Number of Cessations of persons specified in Rule 704(7) of the Listing Manual over the past 12 months *	NIL
Interest in the listed issuer and its subsidiaries *	550,000 shares
Family relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries *	NIL

>> Other Directorship #
# These fields are not applicable for announcements of appointments pursuant to Rule 704(9)
Past (for the last five years) *	No
Present *	No